Abridge

Abridge develops healthcare AI that converts clinical conversations into structured documentation and supports clinical, financial, and evidence-based workflows.

Total funding
$759
Stage
Series E+
Employees
201–500

Company Overview

Abridge is a healthcare artificial intelligence company founded in 2018. It develops AI technology that transforms patient–clinician conversations into structured clinical documentation and supports healthcare workflows across care delivery, medical coding, and reimbursement.

The company’s platform integrates with electronic health record systems to help clinicians prepare for patient visits, document encounters, and generate structured notes, summaries, and other clinical outputs. Its Linked Evidence technology connects AI-generated documentation to source information, helping clinicians review and verify generated content.

QueryFeedz Insight

Abridge operates in the healthcare AI market, where providers are seeking ways to reduce administrative workloads while maintaining the accuracy and completeness of clinical records. Its platform uses AI to transform clinician–patient conversations into structured documentation and connect that information to electronic health record workflows. Linked Evidence is a key part of its approach, allowing users to trace generated documentation back to source information for review.

Funding & Investors

Latest funding
$300
Latest round
Series E+
Latest funding date
June 2026

Investors

  • Andreessen Horowitz (a16z) — Led the Series E round
  • Khosla Ventures
  • Elad Gil
  • IVP
  • Lightspeed Venture Partners
  • Redpoint Ventures
  • Bessemer Venture Partners
  • Spark Capital
  • Union Square Ventures
  • CapitalG
  • CVS Health Ventures
  • Kaiser Permanente Ventures
  • NVIDIA-related investment participation through NVentures in earlier rounds
  • Eli Lilly and Company — Strategic corporate investment announced in June 2026

Founders

  • Shiv Rao MD — Co-Founder and CEO. Sandeep Konam — Co-Founder (reported in third-party company profiles; current role not independently confirmed)